Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

NCT00415363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Small Cell Lung Cancer

Interventions

DRUG: enzastaurin
DRUG: placebo

Sponsor

Eli Lilly and Company